Use of glucagon-like peptide-1 receptor agonists reduces the risk of severe exacerbation in Chinese patients with chronic obstructive pulmonary disease and type 2 diabetes

International Journal of Diabetes in Developing Countries · Published 2026-05-01 · DOI 10.1007/s13410-026-01660-9

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s13410-026-01660-9

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles